Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma
- 1 April 2005
- journal article
- research article
- Published by Elsevier BV in Laboratory Investigation
- Vol. 18 (4), 565-572
- https://doi.org/10.1038/modpathol.3800324
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Differential Gene Expression of Eph Receptors and Ephrins in Benign Human Tissues and CancersClinical Chemistry, 2004
- Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypesExperimental Dermatology, 2003
- Regulation of G1 cell-cycle progression by oncogenes and tumor suppressor genesCurrent Opinion in Genetics & Development, 2002
- Downregulation of the Retinoblastoma Gene Expression in the Progression of Malignant MelanomaPathobiology, 2001
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- RB kinases and RB-binding proteins: new points of viewTrends in Biochemical Sciences, 1997
- Recent Insights into the Functions of the Retinoblastoma Susceptibility Gene ProductCancer Investigation, 1997
- p53‐protein and Ki‐67‐antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skinHistopathology, 1997
- Differential Regulation of Retinoblastoma Protein Function by Specific Cdk Phosphorylation SitesJournal of Biological Chemistry, 1996
- Immunohistochemical expression of retinoblastoma protein in cutaneous melanomasBritish Journal of Dermatology, 1995